Merck & Co., Inc. (MRK)
150.72
-1.83
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
151.39
+0.67
(+0.44%)
After-Hours: 20:00
Merck EPS Diluted (Quarterly) : -0.5405 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5405 |
| March 31, 2026 | -1.715 |
| December 31, 2025 | 1.191 |
| September 30, 2025 | 2.316 |
| June 30, 2025 | 1.762 |
| March 31, 2025 | 2.007 |
| December 31, 2024 | 1.475 |
| September 30, 2024 | 1.242 |
| June 30, 2024 | 2.144 |
| March 31, 2024 | 1.872 |
| December 31, 2023 | -0.484 |
| September 30, 2023 | 1.864 |
| June 30, 2023 | -2.353 |
| March 31, 2023 | 1.106 |
| December 31, 2022 | 1.184 |
| September 30, 2022 | 1.278 |
| June 30, 2022 | 1.553 |
| March 31, 2022 | 1.698 |
| December 31, 2021 | 1.482 |
| September 30, 2021 | 1.801 |
| June 30, 2021 | 0.6083 |
| March 31, 2021 | 1.251 |
| December 31, 2020 | -0.8277 |
| September 30, 2020 | 1.159 |
| June 30, 2020 | 1.184 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.264 |
| December 31, 2019 | 0.9211 |
| September 30, 2019 | 0.7391 |
| June 30, 2019 | 1.03 |
| March 31, 2019 | 1.120 |
| December 31, 2018 | 0.69 |
| September 30, 2018 | 0.73 |
| June 30, 2018 | 0.63 |
| March 31, 2018 | 0.27 |
| December 31, 2017 | -0.39 |
| September 30, 2017 | -0.02 |
| June 30, 2017 | 0.71 |
| March 31, 2017 | 0.56 |
| December 31, 2016 | -0.22 |
| September 30, 2016 | 0.78 |
| June 30, 2016 | 0.43 |
| March 31, 2016 | 0.40 |
| December 31, 2015 | 0.35 |
| September 30, 2015 | 0.64 |
| June 30, 2015 | 0.24 |
| March 31, 2015 | 0.33 |
| December 31, 2014 | 2.54 |
| September 30, 2014 | 0.31 |
| June 30, 2014 | 0.68 |
| March 31, 2014 | 0.57 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Pfizer Inc. | -0.0435 |
| Bristol Myers Squibb Co. | 1.620 |
| Abbott Laboratories | 0.5324 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.337B |
| Revenue (Quarterly) | 16.58B |
| Total Expenses (Quarterly) | 17.92B |
| Enterprise Value | 423.37B |
| Gross Profit Margin (Quarterly) | 71.51% |
| Profit Margin (Quarterly) | -8.06% |
| Earnings Yield | 0.83% |
| Operating Earnings Yield | 3.33% |
| Normalized Earnings Yield | 2.007 |